Matt Paterson

Matt Paterson

Chief Strategy Officer

Executive Leader
About

Matt Paterson is Chief Strategy Officer at Quotient Sciences. With over 27 years of global experience in the pharmaceutical industry, Matt has held leadership roles spanning business development, marketing, and corporate strategy in CRO/CDMO businesses. 

Matt has a keen interest in early clinical research and has been instrumental in advancing Quotient Sciences’ capabilities in this area.

Quotient Sciences Logo
News & Announcements, Articles & Publications

Matthew Paterson, Chief Strategy Officer, Contributes to Clinical Leader

By: Matthew Paterson Download Now

Latest news from Quotient Sciences

More News
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline By: Dr. Andrew Lewis
Read More
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More